International Clinical Trial: Clinical study on the safety and efficacy of JWK010 injection administered as a single suprachoroidal injection in subjects with oculocutaneous albinism type 1 (OCA1)

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115459) titled 'Clinical study on the safety and efficacy of JWK010 injection administered as a single suprachoroidal injection in subjects with oculocutaneous albinism type 1 (OCA1)' on Dec. 26, 2025.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: West China Hospital of Sichuan University

Condition: Oculocutaneous albinism (OCA)

Intervention: Dose 1:JWK010 Injection Low dose: 3 x 10 ^ 11 vg/eye Dose 2:JWK010 injection medium dose: 6 x 10 ^ 11 vg/eye

Recruitment Status: Recruiting

Phase: N/A

Date of First Enrollment: 2025-12-30

Target Sample Size: Dose 1:3;Dose 2:3;Dose 3:3;

Countries ...